You searched for metabolic diseases - Page 3 of 64

News and Trends 19 Jun 2017

This Company Uses the Human Microbiome to Discover New Disease Mechanisms

…role in health and also cause unprecedented damage by starting inflammatory cascades, leading to numerous metabolic diseases. Finding the Link And so, while everybody else was focusing on the human…

June 19, 2017 - 5 minutesmins - By External Contributor

Best in Biotech 28 Nov 2024

Six antisense oligonucleotide companies shaping the future of genetic medicine

…that TGF-β is chronically elevated in many diseases, including ophthalmic and fibrotic diseases and cancer, and involved in their pathophysiology, it is thought to be an extremely versatile drug target…

November 28, 2024 - 10 minutesmins - By Willow Shah-Neville

News and Trends 28 Feb 2023

What’s happening on Rare Disease Day?

…are recent advancements in rare diseases? “There are more than 8,000 known rare diseases that affect over 300 million people globally. Yet only a small percentage of these have treatments…

February 28, 2023 - 8 minutesmins - By Jim Cornall

metabolic disorders chaperones gain thx 1

News and Trends 20 Feb 2018

A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs

…genetic metabolic diseases, and a group of Swiss investors based in Lugano, Switzerland, including TiVenture – no financial data for the deal was disclosed. Gain Therapeutics is looking to apply…

February 20, 2018 - 3 minutesmins - By Alex Dale

Best in Biotech 5 Sep 2024

Six biotech companies that could revolutionize obesity treatments

…numerous investigational drugs to treat cancer, autoimmune diseases, and metabolic diseases like diabetes and obesity. The two notable obesity drugs of the company are HRS9531, a dual agonist of GLP-1/GIP…

September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 2 Apr 2025

Top biotech deals of March 2025

…be designed to potentially treat chronic diseases, including rare, autoimmune, and metabolic diseases. Syneron will receive $75 million in upfront and near-term payments as well as development and commercial milestones…

April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 4 Jan 2024

Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases?

Glucagon-like peptide 1 (GLP-1) agonists have proven their therapeutic mettle in treating metabolic diseases like diabetes and obesity, and now, researchers are studying their effects on cardiovascular disease. These drugs…

January 4, 2024 - 6 minutesmins - By Roohi Mariam Peter

Best in Biotech 19 Dec 2023

Nine biotech companies to watch in 2024

…a variety of diseases, including oncology, autoimmune diseases, blood disorders, and fibrosis. Capstan’s technology centers around targeted lipid nanoparticles (tLNPs) for delivering mRNA payloads to cells. This approach aims to…

December 19, 2023 - 12 minutesmins - By Jules Adam

Best in Biotech 7 Nov 2023

Eight biotech companies tackling infectious diseases head-on

Infectious diseases are diseases that are caused by pathogens that enter the body, hijack the body’s immune system and multiply, causing an infection. Five of the deadliest infectious diseases are…

November 7, 2023 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 28 Feb 2023

10 biotech companies making a difference in rare diseases

…around the world working on and specializing in developing therapies and treatments for people with rare diseases. Research and development involving rare diseases has increased over the past few years,…

February 28, 2023 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 23 Apr 2024

Eight biotechnology companies leading the charge in Poland

…drugs, and has also secured funding from EU programs aimed at fostering innovation. Celon Pharma’s pipeline includes treatments for drug-resistant unipolar depression and metabolic diseases. The company recently completed the…

April 23, 2024 - 7 minutesmins - By Jules Adam

Best in Biotech 13 Mar 2025

Nine biotechs thriving in Seattle in 2025

…most effective for cell-based or antibody-based therapies. With the help of this platform, the company aims to identify and treat autoimmune diseases, cancer, infectious diseases, and neurodegenerative diseases. It has…

March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

This Company Uses the Human Microbiome to Discover New Disease Mechanisms

Six antisense oligonucleotide companies shaping the future of genetic medicine

What’s happening on Rare Disease Day?

A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs

Six biotech companies that could revolutionize obesity treatments

Top biotech deals of March 2025

Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases?

Nine biotech companies to watch in 2024

Eight biotech companies tackling infectious diseases head-on

10 biotech companies making a difference in rare diseases

Eight biotechnology companies leading the charge in Poland

Nine biotechs thriving in Seattle in 2025

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!